Longitude Capital Partners IV, LLC 13D/13G Filings for Zenas BioPharma, Inc. (ZBIO)

Longitude Capital Partners IV, LLC 13D and 13G filings for Zenas BioPharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-14
09:35 am
Purchase
2025-10-0913DZENAS BIOPHARMA INC
ZBIO
Longitude Capital Partners IV, LLC2,631,522
4.900%
129,588increase
(+5.18%)
Filing